OPRX

Edward Stelmakh

Known title: CFO/COOCIK: 0001887046

Edward Stelmakh's purchase track record

Edward Stelmakh has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/15/2022OPRX$46K+36.4%+13.2%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk. OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.

this person other insiders at OPRX

Transaction History

OPRX▼ Sell$11K
OPRX▼ Sell$47K
OPRX▲ Buy$0
OPRX▼ Sell$19K
OPRX▲ Buy$0
OPRX▼ Sell$83K
OPRX▲ Buy$0
OPRX▼ Sell$14K
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▼ Sell$6K
OPRX▼ Sell$14K
OPRX▲ Buy$0
OPRX▼ Sell$33K
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▼ Sell$15K
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▼ Sell$29K
OPRX▼ Sell$99K
OPRX▲ Buy$0
OPRX▲ Buy$0
OPRX▲ Buy$46K

We use analytics to understand how market-wall is used. No personal data is sold.